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Abstract. The osteoconductivity mechanism of hydroxyapatite (HAp) has not been elucidated. 
It is hypothesized that specific proteins absorb on HAp, promoting its osteoconductivity. To 
verify this hypothesis, we compared the adsorption behavior of fibronectin (Fn) on HAp powder 
and on -alumina (-Al2O3) powder, a material with no osteoconductivity. More Fn adsorbed on 
-Al2O3 than on HAp, irrespective of the Fn concentration, and there was no significant 
difference in the secondary structure of Fn adsorbed on HAp and -Al2O3. Further, it is possible 
that Fn did not adsorb on HAp and -Al2O3 through the Arg-Gry-Asp motif of Fn. The amount 
of Fn adsorbed on HAp oriented to the a(b)-axis with very little carbonate decreased and the 
adsorbed Fn had a smaller -helix structure content. The results suggest that the secondary 
and/or higher-order structure rather than the amount of adsorbed Fn might affect the 
osteoconductivity of HAp, which might be electrostatically controlled by crystal face orientation 
and/or carbonate content of HAp, although this should be confirmed by a cell culture test in the 
future. 
1. Introduction 
An ideal artificial bone material is readily available, has a low risk of infection, and is osteoconductive, 
i.e., it has the ability to serve as a scaffold for bone growth and bind to living bone directly [1]. 
Hydroxyapatite (HAp, Ca10(PO4)6(OH)2), the principal inorganic component in the mammal bone and 
tooth [2,3], is an osteoconductive material and artificial HAp is viable in the mammalian body over a 
long period [4–7]. In contrast, -alumina (-Al2O3) has high mechanical strength, abrasion resistance, 
corrosion resistance, and hydrophilicity, supporting its use as an artificial hip joint and artificial tooth 
root in humans since the 1970s [8]. However, -Al2O3 is non-osteoconductive [9–11]. In addition, 
although the osteoconductivity of HAp has been verified, the fundamental mechanism is not fully 
understood. When an osteoconductive material is implanted on a living mammalian bone, 
osteoconduction occurs as follows: (1) protein adsorption from blood and tissue fluids, (2) 
mesenchymal cell recruitment, (3) attachment and proliferation of the mesenchymal cells, (4) 
osteoblast differentiation and osteoid production, (5) matrix calcification, and (6) bone remodeling 
[12,13]. Protein adsorbs on the artificial material in a living mammalian bone immediately, and the 
subsequent cell behavior depends on this process [12]. We previously hypothesized that a putative 
trigger protein first attaches to an implanted osteoconductive material, such as artificial HAp, and 
enhances bone formation and osseointegration in a living mammalian body. We then conducted studies 
to verify this hypothesis [14–16]. In these studies, a larger amount of bovine serum albumin (BSA) 
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adsorbed on -Al2O3 compared to HAp [14,15]. In addition, BSA adsorbed on HAp induced different 
responses from mouse pre-osteoblastic MC3T3-E1 and mouse macrophage-like RAW264.7 cell lines 
compared to BSA adsorbed on -Al2O3 [16]. BSA adsorption on -Al2O3 was non-specific and 
involved electrostatic interaction, while that on HAp was specific and involved ionic interaction. Thus, 
there is a possibility that the specific adsorption of BSA on HAp might play a role in the induction of 
osteoconductivity. 
Fibronectin (Fn) is a 440-kDa dimeric glycoprotein composed of two polypeptide chains [17], 
with a concentration of 140–380 mg·mL–1 (average of 330 mg·mL–1) in the living human body [18] 
and attaches to collagen and gelatin. Fn also binds to cells through integrins, which are representative 
transmembrane receptors for cell-cell and cell-extracellular matrix interactions [19]. Fn contains the 
Arg-Gly-Asp (RGD) motif, a tripeptide occurring in numerous proteins [20,21], in the cell-binding 
domains [18], and the RGD motif shows cell attachment activity [22] by electrostatic interaction with 
integrins [23]. In addition, the peptide-containing RGD motif (RGD-containing peptide) 
competitively inhibits direct interaction between Fn and the proteins that recognize the RGD motif of 
Fn [24–29], and the point-mutated non-polar peptide containing Arg-Gly-Glu (RGE) motif 
(RGE-containing peptide) is widely used as negative control peptide against the RGD-containing 
peptide [28,29]. These functional features of Fn affect the development of cartilage from 
mesenchymal cells in the mammalian bone formation process [18]. In mammals, most parts of the 
bone are formed by cartilage primordial formation, expansion, and cartilaginous ossification [30], 
suggesting that Fn plays an essential role in bone formation. Furthermore, Matsuno et al. implanted 
hydroxyapatite-immobilized collagen and fibronectin (HICF) and collagen-hydroxyapatite into 
full-thickness skull defects of rabbits and found that there were no significant differences in the 
numbers of cells attached to the disks, but cell pseudopodia developed at a noticeably faster rate on 
HICF disks than on collagen-hydroxyapatite [31]. Schönmeyr et al. investigated osteoblast 
attachment and proliferation on porous hydroxyapatite coated with fibronectin together with fetal calf 
serum [32]. In this study, in vitro attachment and proliferation of osteoblasts on porous 
hydroxyapatite was significantly increased by precoating with fibronectin together with fetal bovine 
serum [32]. Thus far, several studies have investigated the adsorption of Fn on HAp. For example, 
Dolatshahi-Pirouz et al. investigated the adsorption of Fn on an HAp-coated Au disc, using the 
uncoated Au disc as a reference [33]. The authors concluded that the detailed molecular structure of 
Fn and its functional activity depend significantly on both the underlying surface chemistry as well as 
the Fn surface coverage. Furthermore, Moraleda et al. investigated the influence of the surface 
features of HAp on the adsorption of Fn based on the hypothesis that the specific surface area (SSA), 
crystallite size (CS), and particle size (PS) affect the adsorption of proteins relevant to bone 
regeneration [34]. The study showed that Fn adsorption on HAp is not determined by a single 
parameter, and a combined analysis of the different parameters is necessary to design materials 
intended for protein interaction. It was also found that the combination of a large SSA and small CS 
favor the adsorption of Fn on HAp whereas the PS plays a modifying role. 
However, the role of Fn as a putative trigger protein for osteoconduction is not well understood. 
In the present study, we compared the adsorption behavior of Fn on osteoconductive HAp and 
non-osteoconductive -Al2O3 to gain further insight into a possible underlying mechanism through 
which Fn adsorption induces the osteoconductivity of HAp. 
2. Materials and methods 
2.1. Sample preparation 
Commercially available HAp powder (ca-HAp; HAP-200, Taihei Chemical Industrial Co. Ltd., Japan), 
-Al2O3 powder (ca-Al2O3; ALO14PB, Kojundo Chemical Lab. Co. Ltd., Japan), and Fn from bovine 
plasma (068-05703, Wako Pure Chemical Industries, Ltd., Japan) were used in the present study. In 
order to examine the effect of crystal orientation on Fn adsorption behavior, HAp powder orientated to 
the c-axis (a(b)-HAp) was prepared using the urea homogenous precipitation method [35,36] and those 
oriented to the a(b)-axis (c-HAp) were prepared according to Zhuang’s method [36]. In addition, in 
order to investigate the adsorption site of Fn for ca-HAp or ca-Al2O3, carboxy fluorescein-aminohexyl 
amidite (FAM)-aminohexanoic acid (Ahx)-GRGDSP (K3038, Toray Research Center, Inc., Japan; 
purity: 95%, molecular weight: 1059.0) and FAM-Ahx-GRGESP (K3039, Toray Research Center, Inc., 
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Japan; purity: 95%, molecular weight: 1073.1) peptides were used as RGD- and RGE-containing 
peptides, respectively. The FAM’s excitation and emission wavelengths were 495 nm and 521 nm, 
respectively [37]. 
2.2. Sample characterization 
The morphology of the samples was observed by scanning electron microscope (SEM; VE-8800, 
Keyence Corp., Japan). Crystalline phases of these materials were identified with an X-ray 
diffractometer (XRD; MiniFlex600, Rigaku Corp., Japan) with the following conditions: X-ray source, 
Cu-K, X-ray power, 40 kV, 15 mA, scanning rate, 2 = 2 degree·min–1, and sampling angle, 0.01 
degree. The structure of HAp samples was investigated by Fourier-Transform Infrared spectroscopy 
(FT-IR; FT/IR-6200, Jasco Corp., Japan). For the FT-IR measurement, we used a potassium bromide 
(KBr) pellet method with a sample/KBr weight ratio of 1/800 at a resolution of 4 cm–1 and a cumulated 
number of 16. Samples HAps (ca-HAp, a(b)-HAp, and c-HAp) and ca-Al2O3 were previously heated 
for 2 h at 200 and 300°C, respectively, and the specific surface area (SSA) of these materials was 
measured using the Brunauer-Emmett-Teller (BET) technique (Autosurb®-iQ-MP, Quantachrome 
Instruments, USA). Commercially available bovine plasma Fn (068-05703, Wako Pure Chemical 
Industries, Ltd., Japan) was used in this study. The zeta potentials of the HAp samples, ca-Al2O3, and 
Fn in phosphate-buffered saline (PBS; 166-23555, Wako Pure Chemical Industries, Ltd., Japan) or 
PBS, including the synthetic RGD- or RGE-containing peptides at 35°C, were measured with 
electrophoresis spectroscopy (ELS-Z, Zetasizer Nano ZS90, Malvern Instruments Ltd., UK). 
2.3. Measurement of Fn adsorption on samples 
Fn was dissolved in PBS for 24 h at 4°C to obtain Fn solutions with different concentrations ranging 
from 0.10–0.45 mg·mL–1. Tubes containing 5 mg ca-HAp and 11.5 mg ca-Al2O3 were incubated with 
1.5 and 3.0 mL Fn solutions with different concentrations, respectively, at 36.5°C for 1 h while rotating 
at 5 rpm using a tube rotator (TR-350, As One Corp., Japan). The mixture was centrifuged for 10 min at 
10,000 rpm (H-201F, Kokusan Co., Ltd., Japan), and the supernatant was collected by micropipette 
(Nichipet EXII, Nichiryo Co., Ltd., Japan). The supernatant (100 µL) was put into a 70 µL-disposable 
cell (UV-Cuvette micro, BrandTech Scientific Inc., UK) and the concentration of Fn in the supernatant 
was measured by a UV-Vis spectrometer (V-730BIO, Jasco Corp., Japan). For the Fn concentration 
measurement, the ultraviolet absorption method with optical path length of 10 mm was employed and 
the Fn concentration was estimated by the Warburg-Christian method [38]. The adsorbed amount of Fn 
was calculated using the Fn concentration in the supernatant. A similar measurement was performed 
for samples a(b)-HAp and c-HAp in 0.45 mg·mL–1 Fn solution. 
The Hill equation was used for analysis of the Fn adsorption isotherm. 
𝑞 =
𝐾ℎ𝐶
𝑛𝑞0
1+𝐾ℎ𝐶𝑛
                                    (1) 
where q is the amount of adsorption, q0 is the saturated amount of adsorption, Kh is the equilibrium 
constant in the Hill model, C is the equilibrium concentration, and n is the Hill coefficient. The 
parameters Kh, q0, and n were calculated using the ORIGIN software (Origin
® 2015, Originlab Corp., 
U. S.) by nonlinear least-squares fitting to the adsorption isotherm data. 
Further, the adsorption capacity of Fn on samples ca-HAp and ca-Al2O3 in Fn solutions with 
RGD-containing peptide or RGE-containing peptide (Fn-peptide mixed solutions) was measured. The 
concentrations of Fn and RGD- or RGE-containing peptide in the Fn-peptide mixed solutions were 
0.15 mg·mL–1 and 0.1 µmol·mL–1, respectively. The incubation conditions were the same as those 
described above but the incubation period was changed to 30 min. The concentration of RGD- or 
RGE-containing peptide (Cpeptide) in the supernatant of the Fn-peptide mixed solutions after 
incubation was measured by fluorescence by exciting the peptide using visible-light at a wavelength 
of 495 nm. The concentration of proteins associated with Fn and peptides (Cprotein) in the same 
supernatant were measured by a UV-Vis spectrometer in the manner described above. Then, the Fn 
concentration in the supernatant was estimated by subtracting Cpeptide from Cprotein, and the adsorption 
capacity of Fn on the samples was calculated from the Fn concentration in the supernatant. The 
results are expressed as mean ± standard deviation. Statistical significance was set to P < 0.05 and 
was calculated using Student’s t test. 
2.4. Measurement of secondary structure of Fn adsorbed on the samples 
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The secondary structure of Fn adsorbed on the samples was measured by FT-IR spectroscopy as 
follows. Samples soaked in Fn solutions were freeze-dried (FD-1000, Tokyo Rikakikai, Tokyo). A 
moderate amount of the freeze-dried samples were placed on the KBr plate (2000-0060, Jasco, 
Tokyo) and pressed with another KBr plate at a pressure of 10 kN to form a KBr pellet 5 mm in 
diameter. The KBr pellet was subjected to FT-IR measurement at a resolution of 4 cm–1 and a 
cumulated number of 16. The absorption bands of Fn at 1600–1700 cm–1 were deconvoluted by 
principal components regression analysis using a protein secondary structure analysis software (IR 
SSE-4000, Jasco Corp., Japan). 
3. Results and discussion 
Figure 1 shows the XRD pattern of the samples a(b)-HAp, ca-HAp, c-HAp and ca-Al2O3. Samples 
ca-HAp, a(b)-HAp, and c-HAp had several XRD peaks ascribed to hydroxyapatite (PDF 
#01-071-5049). Samples a(b)-HAp and c-HAp showed high diffraction intensities of hydroxyapatite 
crystal faces (300) and (002), respectively, indicating that the expected crystal orientation of 
hydroxyapatite was achieved. Sample ca-Al2O3 had XRD peaks ascribed to -Al2O3 (PDF 
#00-046-1212), indicating that the sample ca-Al2O3 contained no unwanted crystalline phases that 
may have affected the accuracy of the experimental results. 
 
 
Figure 1. XRD patterns of samples a(b)-HAp, ca-HAp, c-HAp and ca-Al2O3. 
 
Figure 2 shows the SEM images of the samples ca-HAp, ca-Al2O3, a(b)-HAp and c-HAp. 
Samples ca-HAp and ca-Al2O3 were composed of very fine particles that formed agglomerates and 
short chains. The agglomerates in samples ca-HAp and ca-Al2O3 had sizes ranging from 5–20 µm and 
1–20 µm, respectively. Samples a(b)-HAp and c-HAp had rod- and a plate-like shapes, respectively. 
This remarkable difference in sample morphology can be attributed to the difference in 
hydroxyapatite crystal orientation in these samples, which was confirmed by the XRD analysis 
(Figure 1). 
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Figure 2. SEM images of samples ca-HAp, ca-Al2O3, a(b)-HAp and c-HAp. 
 
Figure 3 shows the FT-IR spectra of samples a(b)-HAp, ca-HAp, and c-HAp. As shown in 
Figure 3(a), all samples had FT-IR absorption bands ascribed to phosphate (PO4
3–), carbonate (CO3
2–), 
the hydroxyl group (OH–), and adsorbed H2O [39–41]. The absorption bands of CO3
2– were observed 
for samples a(b)-HAp and ca-HAp but not for sample c-HAp, indicating that samples a(b)-HAp and 
ca-HAp contained CO3
2– but sample c-HAp contained very little CO3
2– [40,41]. Figure 3(b) shows the 
FT-IR spectra of samples in wavenumbers ranging from 1300–1600 cm–1. The absorption bands 
could be attributed to CO3
2– replacing PO4
3– of the hydroxyapatite crystal (type B replacement) 
[40,41]. Table 1 shows the SSAs and zeta potentials of the samples and Fn in PBS. It can be seen 
from the zeta potential that HAp samples (ca-HAp, a(b)-HAp, and c-HAp) and Fn were negatively 
charged while -Al2O3 was positively charged. The mass of ca-HAp and ca-Al2O3 used in the 
following Fn adsorption test was determined using the SSAs of ca-HAp and ca-Al2O3 so that ca-HAp 
and ca-Al2O3 had the same surface area of 0.04 m
2. 
 
  
Figure 3. FT-IR spectra of samples a(b)-HAp, ca-HAp, and c-HAp, which were measured in 
different wavenumbers ((a): 400–4000 cm–1, (b): 1300–1600 cm–1). 
 
Table 1. SSAs and zeta potentials of samples. 
Sample SSA [m2·g–1] Zeta potential [mV] 
ca-HAp 8.3 -13.8 
ca-Al2O3 3.6 1.70 
(a)b-HAp 5.1 -7.01 
c-HAp 18.9 -29.1 
 
Figure 4 shows the amount of Fn adsorbed on samples ca-HAp and ca-Al2O3 as a function of Fn 
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concentration ranging from 0.10–0.45 mg·mL–1. Sample ca-HAp showed higher Fn adsorption 
capability (1.77–4.10 mg·m–2) than sample ca-Al2O3 (2.44–11.7 mg·m
–2), irrespective of the Fn 
solution concentration. The amount of Fn adsorbed on sample ca-HAp was almost constant at Fn 
concentrations between 0.10–0.45 mg·mL–1 and there was no significant difference in the Fn 
adsorption capacity of ca-Al2O3 between the Fn concentrations of 0.35 mg·mL
–1 and 0.45 mg·mL–1. 
The Langmuir equation is often used for analysis of the adsorption isotherm, but when interactions 
between adsorbed proteins are not negligible, the Hill equation is used [33,42,43]. The determination 
coefficients (R2) for the Fn adsorption isotherm on ca-HAp and ca-Al2O3 calculated using the Hill 
equation were 0.9857 and 0.9515, respectively, indicating that the Fn adsorption isotherm was 
well-approximated by the Hill equation. A Hill coefficient (n) larger than 1.0 (ca-HAp: 1.888, 
ca-Al2O3: 1.684) implies an attractive interaction between Fn adsorbed on both samples [33]. 
The higher adsorption capability of sample ca-Al2O3 compared to sample ca-HAp might be 
attributed to the electrostatic attraction between positively charged sample ca-Al2O3 and negatively 
charged Fn (Table 1). On the other hand, although electrostatic repulsion would have occurred 
between negatively charged sample ca-HAp and negatively charged Fn, certain amounts of Fn 
adsorbed on sample ca-HAp, implying that Fn can adsorb specifically on sample ca-HAp despite the 
electrostatic repulsion. Table 2 shows the secondary deconvoluted structure of Fn adsorbed on 
samples ca-HAp and ca-Al2O3. There was no significant difference in the secondary structure of Fn 
adsorbed on these samples. This result implies that the secondary structure of Fn has little influence 
on the Fn adsorption capacity of ca-HAp and ca-Al2O3. 
 
Figure 4. Adsorption capacity of Fn on samples ca-HAp and ca-Al2O3 as a function of Fn 
concentration of 0.10–0.45 mg·mL–1. 
 
Table 2. Secondary structure of Fn adsorbed on samples. 
Sample -helix -sheet -turn others 
ca-HAp 15 34 24 27 
ca-Al2O3 12 35 24 29 
(a)b-HAp 13 35 25 27 
c-HAp 3 43 22 32 
 
Figure 5 shows the amount of Fn adsorbed on samples ca-HAp, a(b)-HAp, and c-HAp at an Fn 
concentration of 0.45 mg·mL–1. There were significant differences in the Fn adsorption capacity of 
these samples and the order of Fn adsorption capacity was a(b)-HAp > HAp > c-HAp. Table 2 shows 
the secondary structure of Fn adsorbed on these samples. Interestingly, the content of the -helix in 
Fn adsorbed on sample c-HAp was lower than those on samples ca-HAp and a(b)-HAp, which 
implies that Fn hardly denature on c-HAp. In fact, a previous study estimated 47% -sheet, 28% turn, 
and 25% unordered structures, which were closer to those of Fn adsorbed on c-HAp than on other 
samples (Table 2), for non-adsorbed Fn in aqueous-buffered solution [44]. It has been reported that a 
small amount of -helix structure [45] is contained in the collagen-binding domain [46], cell-binding 
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domain [47], and domain of unknown function [40] of Fn, and the calculated isoelectric points of 
these domains were 3.56–5.52 [45–48], indicating that these domains are negatively charged in the 
human body. In addition, Osterlund et al. reported that Fn denatured to change the -sheet to an 
-helix inversely [49]. Based on the present results and the above findings, we can speculate that Fn 
was denatured and the -helix of Fn increased to adsorb on ca-HAp and a(b)-HAp. On the other hand, 
HAp has different atomic arrangements on the two types of crystal planes; a(b)-plane and c-plane. 
The difference between the a(b)-plane and the c-plane is as follows: the a(b)-plane is rich in calcium 
ions and is positively charged, while the c-plane is rich in phosphate and hydroxide ions and is 
negatively charged [50–52]. As shown in Figure 2, samples a(b)-HAp and c-HAp mainly had 
positively charged a(b)-planes and negatively charged c-planes, respectively. Therefore, the adhesion 
of negatively charged Fn was inhibited on c-HAp with a negatively charged c-face. Here, it is also 
noted that sample c-HAp is characterized by its extremely low content of carbonate (Figure 3). The 
difference in the carbonate content might change the charged state of the HAp crystal face [53], 
resulting in even lower adsorption capacity of Fn on c-HAp. The above results imply that the 
secondary and/or higher-order structure rather than the amount of adsorbed Fn plays an important 
role in the osteoconductivity of HAp and it is partially controlled by the crystal face orientation of 
HAp. 
 
 
Figure 5. Adsorption capacity of Fn on samples ca-HAp, a(b)-HAp, and c-HAp at an Fn 
concentration of 0.45 mg·mL–1. 
 
Fn has an RGD motif in the cell attachment domain, which raises the possibility that Fn adsorbs 
on osteoconductive materials, such as HAp, to expose its RGD motif to osteoblasts and/or osteoclasts 
that mainly mediate bone formation and its remodeling. This is based on the assumption that HAp 
does not have the adsorption site of the RGD motif and/or Fn does not adsorb on the materials 
through the RGD motif. Therefore, adsorption behavior of Fn on samples ca-HAp and ca-Al2O3 in Fn 
solution with synthetic RGD-containing peptide (FAM-Ahx-GRGDSP, see Materials and methods 
for detail) and point-mutated RGE-containing peptide (FAM-Ahx-GRGESP, see Experimental for 
detail) without cell attachment activity (as reference) was investigated in the present study. If the Fn 
adsorbs on samples ca-HAp and ca-Al2O3 via the RGD motif, the adsorption behavior of Fn would 
remarkably change in Fn solution with RGD-containing peptide because the RGD motif in Fn 
becomes inactivated by the RGD-containing peptide. The Fn still showed negative zeta potentials in 
the solution with RGD- (–5.2 mV) or RGE-containing peptide (–7.4 mV), suggesting that the 
addition of RGD- or RGE-containing peptide hardly affects the surface charge of Fn in the solution. 
Figure 6 shows the adsorption capacity of Fn on these samples in Fn solution with RGD- or 
RGE-containing peptide. As described before, the RGD-containing peptide has been widely used as a 
competitive inhibitor of direct protein association with the RGD motif within Fn, and the 
RGE-containing peptide with non-polar characteristics has also been used as an inactive control 
peptide against RGD-containing peptide in previous studies. For each sample material (ca-HAp or 
ca-Al2O3) of the present study, the point-mutated and inactive RGE-containing peptides in Fn 
solution had no statistically significant effect on the adsorption capacity of Fn on the employed 
materials, compared to the parental and active RGD-containing peptides in Fn solution. The results 
suggest that Fn adsorbs on samples ca-HAp and ca-Al2O3 not via the RGD motif. Figure 7 shows a 
schema of possible adsorption of Fn on HAp based on the presumption that Fn adsorbs on HAp 
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though the collagen-binding domain but not the RGD motif of Fn. This schema was created based on 
the reported phenomenon that Fn binds to collagen in vitro [20,54]. As shown in this schema, the 
RDG motif might be exposed to enhance osteoblast and/or osteoclast cell adhesion, resulting in 
expression of osteoconductivity when Fn adsorbed on HAp. The above hypothesis will be confirmed 
by a cell culture test in the future. 
 
 
Figure 6. Adsorption capacity of Fn on samples ca-HAp and ca-Al2O3 in Fn solution with 
RGD-containing peptide, RGE-containing peptide, or no peptide. 
 
 
Figure 7. Schema of possible adsorption of Fn on HAp based on the presumption that Fn adsorbs on 
HAp though the collagen-binding domain. 
4. Conclusions 
We examined Fn adsorption on osteoconductive HAp and non-osteoconductive -Al2O3. A larger 
amount of Fn adsorbed on -Al2O3 than HAp irrespective of Fn concentration and there was no 
significant difference in secondary structure of Fn adsorbed on HAp and -Al2O3. Further, we 
pharmacologically showed that Fn did not adsorb on HAp and -Al2O3 through the RGD motif of Fn. 
On the other hand, the amount of Fn adsorbed on HAp oriented to the a(b)-axis (showing relatively 
lower carbonate content) decreased and the adsorbed Fn had a smaller -helix structure content. 
Taken together, the present results suggest that the secondary and/or higher-order structure rather 
than the amount of adsorbed Fn might affect the osteoconductivity of HAp, which could be 
electrostatically controlled by crystal face orientation and/or the carbonate content of HAp, although 
this should be confirmed by a cell culture test in the future. 
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